Sign in Subscribe
Diseases

Advances in ABO-Incompatible Kidney Transplants for Children

Strategic Insights

— 1 min read

Younger children with kidney failure may soon have more options for transplantation thanks to advancements in ABO-incompatible kidney transplantation (ABOiKT). This approach can overcome the initial challenge of hyperacute rejection, but requires careful pre- and post-transplant management. Investigators have made significant progress in refining protocols and improving outcomes for children with kidney failure.

Key Takeaways:

  • ABOiKT can provide hope for children with kidney failure, especially in areas with limited donor availability and long waiting times.
  • Younger children have immunological advantages due to lower baseline isohaemagglutinin titres and a more adaptable immune system.
  • Pre-transplant desensitisation strategies have evolved from invasive surgical procedures to less invasive medical treatments, combining plasmapheresis or immunoadsorption with intravenous rituximab and/or low-dose intravenous immunoglobulin.
  • Post-transplant management includes close monitoring for antibody-mediated rejection, infectious complications, and continuation of standard maintenance immunosuppressive regimens.
  • Graft outcomes remain comparable to ABO compatible kidney transplantation (ABOcKT) but the risk of infectious complications, requirement for intensive desensitisation procedures, and lack of standardised desensitisation protocols are challenging.
  • Further refinement of protocols through information gained from multicentre collaboration and long-term outcome data is the current requirement to establish the position of ABOiKT in the management ladder for children with kidney failure.
  • Investigators have identified the need for standardised desensitisation protocols and improved post-transplant care to further improve outcomes.
  • The research was conducted at the Institute of Kidney Diseases and Research Centre in Ahmedabad, India.

Statistics:

  • The risk of infectious complications in ABOiKT patients is a significant challenge, with [no specific percentage or data provided in the original text].
  • The requirement for intensive desensitisation procedures is a major consideration in ABOiKT, with [no specific data provided in the original text].
  • Graft outcomes in ABOiKT patients are comparable to ABOcKT, with [no specific data provided in the original text].
  • The lack of standardised desensitisation protocols is a significant limitation of ABOiKT, with [no specific data provided in the original text].

Sources:

  • Pediatric Nephrology, 2025: The history and future landscape for paediatric ABO incompatible kidney transplantation.
  • NewsRx LLC, 2025: Studies in the Area of Kidney Transplants Reported from Institute of Kidney Diseases and Research Centre.

Read more